4//SEC Filing
Weisman Harlan F 4
Accession 0001213900-22-078039
CIK 0001733413other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 9:39 PM ET
Size
5.8 KB
Accession
0001213900-22-078039
Insider Transaction Report
Form 4
Weisman Harlan F
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-12-03+1,792,450→ 1,792,450 totalExercise: $1.19Exp: 2032-12-03→ Common Stock (1,792,450 underlying)
Footnotes (1)
- [F1]The Options shall vest during the period of Dr. Weisman's service as CEO of the Company as follows: Options to purchase 298,750 shares of Common Stock ("Six Month Options") shall vest upon the six-month anniversary of the date of grant and Options to purchase 49,790 shares of Common Stock shall vest in 30 monthly installments commencing on the seven-month anniversary of the date of grant. In the event of the Company's termination of Dr. Weisman's service as CEO ("Termination of Service") as a result of hiring a permanent CEO all unvested Options shall immediately expire.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001555563
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 9:39 PM ET
- Size
- 5.8 KB